MDGL stock news
This page provides real-time market news, earnings updates, and company announcements related to Madrigal Pharmaceuticals, Inc. (MDGL).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-13 13:33 EST
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
101 finance2026-01-09 16:30:23
Kailera’s Ron Renaud discusses how a startup with connections to China can stand out in the obesity market
101 finance2026-01-20 12:09:29
Madrigal Pharmaceuticals, Inc. announced an exclusive global licensing agreement to introduce six preclinical-stage siRNA (small interfering RNA) programs, aiming to significantly expand its research and development pipeline for metabolic dysfunction-associated steatohepatitis (MASH).
老虎证券2026-02-11 10:07:01
MDGL stock chart
MDGL stock detailsMDGL stock price change
On the last trading day, MDGL stock closed at 478.51 USD, with a price change of -0.52% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more